Frederik Anton Verburg

1998-2004: Medical School, UMC Utrecht, Utrecht, the Netherlands.
2005-2007: Assistent physician, UMC Utrecht, Department of Nuclear Medicine, Utrecht.

Publications:

1. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients.
2. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
3. Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
4. A comparison of prognostic classification systems for differentiated thyroid carcinoma
   Frederik A Verburg.
5. No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.
6. Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience.
7. The association between multinodular goiter and thyroid cancer.
8. (131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies.
9. The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patients.
10. Intratracheal growth of recurrent benign goiter.